Canaccord analyst William Plovanic raised the firm’s price target on Nevro to $76 from $72 and keeps a Buy rating on the shares. The analyst said given strength of reports from competitive players, we believe that the overall SCS market has stabilized and could begin to grow through this year, setting up Nevro nicely through 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVRO:
- Nevro backs FY23 revenue view $445M-$455M, consensus $448.91M
- Nevro sees Q2 $110M-$112M, consensus $111.52M
- Nevro reports Q1 EPS (98c), consensus ($1.04)
- Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
- Nevro announces enrollment of first patient in PDN sensory study
